Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
DOYLE THOMAS JAMES
SVP, Finance & Accounting at Kura Oncology. Filing since 27 Jan 2023.
CIK 0001910331
Company
Date
Role
Action
Shares
Amount
Of holding
KURA
Kura Oncology, Inc.
28 Sep 2026
SVP, Finance & Accounting
Sold at will
4,607
$48.36K
3.1%
KURA
Kura Oncology, Inc.
27 Jan 2026
SVP, Finance & Accounting
Sold at will
7,142
$60.43K
4.7%
KURA
Kura Oncology, Inc.
14 Nov 2025
SVP, Finance & Accounting
Sold at will
4,539
$50.73K
3.4%
KURA
Kura Oncology, Inc.
29 Sep 2025
SVP, Finance & Accounting
Sold at will
4,541
$40.61K
4.0%
KURA
Kura Oncology, Inc.
28 Jan 2025
SVP, Finance & Accounting
Sold at will
4,949
$38.96K
5.3%
KURA
Kura Oncology, Inc.
29 Jan 2024
SVP, Finance & Accounting
Sold at will
2,318
$41.26K
4.6%
KURA
Kura Oncology, Inc.
27 Jan 2023
SVP, Finance & Accounting
Sold, plan not stated
1,548
$21.50K
8.4%
7 decisions on file.
